R Squared’s Nexalin Technology NXL Stock Holding History

R Squared’s Portfolio NXL Stock Details NXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-790	Closed	-$2.18K	–	1097
2024 Q4	$2.18K	Buy	+790	New	+$2.2K	﹤0.01%	1457

Other funds holding NXL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

DWM

Drive Wealth Management Lehi, Utah $474M AUM 23.44% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

AWS

Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $7.33B AUM 16.07% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

R Squared's NXL Position: Q1 2025 in Review

R Squared sold out of Nexalin Technology (NXL) in Q1 2025, closing a stake of 790 shares — an estimated $2.18K sold.

R Squared first reported a position in NXL in Q4 2024 and held it in 1 quarter. The position peaked at $2.18K in Q4 2024. 17 funds tracked by Wall St. Rank hold NXL as of Q1 2025.

R Squared reported no remaining Nexalin Technology position as of Q1 2025 after selling out during the quarter.
R Squared sold 790 Nexalin Technology shares in Q1 2025, an estimated $2.18K.
R Squared first reported a position in Nexalin Technology in Q4 2024 and held it in 1 quarter.
R Squared's Nexalin Technology position peaked at $2.18K in Q4 2024.
17 funds tracked by Wall St. Rank held Nexalin Technology as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.